documents: FDA-2014-D-0622-0021

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-D-0622-0021 FDA FDA-2014-D-0622 Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry Other Guidance 2020-12-09T05:00:00Z 2020 12 2020-12-09T05:00:00Z   2024-11-06T23:42:55Z   1 0 090000648498e3cc

Links from other tables